FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Olympus Scope Import Alerts

FDA tells healthcare providers to be aware of import alerts for specific Olympus medical devices that are being refused entry into the U.S. due to ong...

latest-news-card-1
Human Drugs

Davis Returning to CDER as Deputy Director

FDA says Usona Institute chief medical officer Michael C. Davis is returning to CDER as the Centers deputy director after being gone two and a half ye...

latest-news-card-1
Human Drugs

CGMP Issues in Pushclean Records Review

FDA warns Turkeys Pushclean Technology about CGMP violations in its manufacturing of over-the-counter drug products.

latest-news-card-1
Medical Devices

QS, MDR Violations at S. Koreas Aju Pharm

FDA warns South Koreas Aju Pharm about QS and MDR violations in its production of two Class 2 medical devices.

latest-news-card-1
Biologics

FDA Skips Panel Review for Capricor Cell Therapy

FDA says there will be no advisory committee review of Capricor Therapeutics BLA for Deramiocel, the companys lead cell therapy candidate for treating...

latest-news-card-1
Human Drugs

CDER Acting Head Corrigan-Curay Leaving in July

CDER acting director Jacqueline Corrigan-Curay decides to retire and will leave her post next month.

latest-news-card-1
Medical Devices

GE Recalls Carestation Anesthesia Devices

GE HealthCare recalls certain Carestation anesthesia devices due to the risk that they may not provide effective ventilation in certain situations.

latest-news-card-1
Human Drugs

Bimagrumab Enhances Weight Loss: Study

New data from a Phase 2 study on Eli Lillys experimental bimagrumab showed that when combined with Novo Nordisk's Wegovy (semaglutide) it led to prese...

latest-news-card-1
Human Drugs

Guideline on Drug Stability Testing Released

FDA posts an International Council for Harmonization draft guideline entitled Stability Testing of Drug Substances and Drug Products Q1.

latest-news-card-1
Human Drugs

Inspections Help Prevent Drug Shortages: Study

A new study disputes previous assumptions about FDA inspections leading to more drug shortages at facilities receiving GMP citations.